Global and United States Oncology/Cancer Drugs Market Report & Forecast 2022-2028

Global and United States Oncology/Cancer Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Oncology/Cancer Drugs Product Introduction
1.2 Global Oncology/Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oncology/Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oncology/Cancer Drugs Sales in Volume for the Year 2017-2028
1.3 United States Oncology/Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oncology/Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oncology/Cancer Drugs Sales in Volume for the Year 2017-2028
1.4 Oncology/Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oncology/Cancer Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oncology/Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oncology/Cancer Drugs Market Dynamics
1.5.1 Oncology/Cancer Drugs Industry Trends
1.5.2 Oncology/Cancer Drugs Market Drivers
1.5.3 Oncology/Cancer Drugs Market Challenges
1.5.4 Oncology/Cancer Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oncology/Cancer Drugs Market Segment by Type
2.1.1 Antimetabolite
2.1.2 Alkaloid drugs
2.1.3 Hormone
2.1.4 Targeted drug
2.1.5 Platinum-based drugs
2.1.6 Other
2.2 Global Oncology/Cancer Drugs Market Size by Type
2.2.1 Global Oncology/Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oncology/Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oncology/Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oncology/Cancer Drugs Market Size by Type
2.3.1 United States Oncology/Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oncology/Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oncology/Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oncology/Cancer Drugs Market Segment by Application
3.1.1 Blood Cancer
3.1.2 Breast Cancer
3.1.3 Gastrointestinal Cancer
3.1.4 Prostate Cancer
3.1.5 Respiratory/Lung Cancer
3.1.6 Other
3.2 Global Oncology/Cancer Drugs Market Size by Application
3.2.1 Global Oncology/Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oncology/Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oncology/Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oncology/Cancer Drugs Market Size by Application
3.3.1 United States Oncology/Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oncology/Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oncology/Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oncology/Cancer Drugs Competitor Landscape by Company
4.1 Global Oncology/Cancer Drugs Market Size by Company
4.1.1 Top Global Oncology/Cancer Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oncology/Cancer Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Oncology/Cancer Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Oncology/Cancer Drugs Price by Manufacturer (2017-2022)
4.2 Global Oncology/Cancer Drugs Concentration Ratio (CR)
4.2.1 Oncology/Cancer Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oncology/Cancer Drugs in 2021
4.2.3 Global Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oncology/Cancer Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Oncology/Cancer Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oncology/Cancer Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oncology/Cancer Drugs Market Size by Company
4.5.1 Top Oncology/Cancer Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oncology/Cancer Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oncology/Cancer Drugs Sales by Players (2020, 2021 & 2022)
5 Global Oncology/Cancer Drugs Market Size by Region
5.1 Global Oncology/Cancer Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oncology/Cancer Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Oncology/Cancer Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Oncology/Cancer Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oncology/Cancer Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Oncology/Cancer Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Oncology/Cancer Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oncology/Cancer Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Oncology/Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oncology/Cancer Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oncology/Cancer Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oncology/Cancer Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Oncology/Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oncology/Cancer Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Oncology/Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oncology/Cancer Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oncology/Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Roche
7.1.1 Roche Corporation Information
7.1.2 Roche Description and Business Overview
7.1.3 Roche Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Roche Oncology/Cancer Drugs Products Offered
7.1.5 Roche Recent Development
7.2 HENGRUI
7.2.1 HENGRUI Corporation Information
7.2.2 HENGRUI Description and Business Overview
7.2.3 HENGRUI Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 HENGRUI Oncology/Cancer Drugs Products Offered
7.2.5 HENGRUI Recent Development
7.3 AstraZeneca
7.3.1 AstraZeneca Corporation Information
7.3.2 AstraZeneca Description and Business Overview
7.3.3 AstraZeneca Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 AstraZeneca Oncology/Cancer Drugs Products Offered
7.3.5 AstraZeneca Recent Development
7.4 QILU
7.4.1 QILU Corporation Information
7.4.2 QILU Description and Business Overview
7.4.3 QILU Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 QILU Oncology/Cancer Drugs Products Offered
7.4.5 QILU Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Oncology/Cancer Drugs Products Offered
7.5.5 Sanofi Recent Development
7.6 HANSOH
7.6.1 HANSOH Corporation Information
7.6.2 HANSOH Description and Business Overview
7.6.3 HANSOH Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 HANSOH Oncology/Cancer Drugs Products Offered
7.6.5 HANSOH Recent Development
7.7 LUYE
7.7.1 LUYE Corporation Information
7.7.2 LUYE Description and Business Overview
7.7.3 LUYE Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 LUYE Oncology/Cancer Drugs Products Offered
7.7.5 LUYE Recent Development
7.8 Novartis
7.8.1 Novartis Corporation Information
7.8.2 Novartis Description and Business Overview
7.8.3 Novartis Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Novartis Oncology/Cancer Drugs Products Offered
7.8.5 Novartis Recent Development
7.9 GuiZhou YiBai
7.9.1 GuiZhou YiBai Corporation Information
7.9.2 GuiZhou YiBai Description and Business Overview
7.9.3 GuiZhou YiBai Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 GuiZhou YiBai Oncology/Cancer Drugs Products Offered
7.9.5 GuiZhou YiBai Recent Development
7.10 Lunan
7.10.1 Lunan Corporation Information
7.10.2 Lunan Description and Business Overview
7.10.3 Lunan Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Lunan Oncology/Cancer Drugs Products Offered
7.10.5 Lunan Recent Development
7.11 Eli Lilly and Company
7.11.1 Eli Lilly and Company Corporation Information
7.11.2 Eli Lilly and Company Description and Business Overview
7.11.3 Eli Lilly and Company Oncology/Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Eli Lilly and Company Oncology/Cancer Drugs Products Offered
7.11.5 Eli Lilly and Company Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oncology/Cancer Drugs Industry Chain Analysis
8.2 Oncology/Cancer Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oncology/Cancer Drugs Distributors
8.3 Oncology/Cancer Drugs Production Mode & Process
8.4 Oncology/Cancer Drugs Sales and Marketing
8.4.1 Oncology/Cancer Drugs Sales Channels
8.4.2 Oncology/Cancer Drugs Distributors
8.5 Oncology/Cancer Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Oncology/Cancer Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Oncology/Cancer Drugs Market Trends
Table 3. Oncology/Cancer Drugs Market Drivers
Table 4. Oncology/Cancer Drugs Market Challenges
Table 5. Oncology/Cancer Drugs Market Restraints
Table 6. Global Oncology/Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Oncology/Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Oncology/Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Oncology/Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Oncology/Cancer Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Oncology/Cancer Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Oncology/Cancer Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Oncology/Cancer Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Oncology/Cancer Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Oncology/Cancer Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Oncology/Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Oncology/Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology/Cancer Drugs as of 2021)
Table 18. Top Players of Oncology/Cancer Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Oncology/Cancer Drugs Product Type
Table 20. Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Oncology/Cancer Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Oncology/Cancer Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Oncology/Cancer Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Oncology/Cancer Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Oncology/Cancer Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Oncology/Cancer Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Oncology/Cancer Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Oncology/Cancer Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Oncology/Cancer Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Oncology/Cancer Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Oncology/Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Oncology/Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Oncology/Cancer Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Oncology/Cancer Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Oncology/Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Oncology/Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Oncology/Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Oncology/Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Oncology/Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Oncology/Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Roche Corporation Information
Table 43. Roche Description and Business Overview
Table 44. Roche Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Roche Oncology/Cancer Drugs Product
Table 46. Roche Recent Development
Table 47. HENGRUI Corporation Information
Table 48. HENGRUI Description and Business Overview
Table 49. HENGRUI Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. HENGRUI Product
Table 51. HENGRUI Recent Development
Table 52. AstraZeneca Corporation Information
Table 53. AstraZeneca Description and Business Overview
Table 54. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. AstraZeneca Product
Table 56. AstraZeneca Recent Development
Table 57. QILU Corporation Information
Table 58. QILU Description and Business Overview
Table 59. QILU Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. QILU Product
Table 61. QILU Recent Development
Table 62. Sanofi Corporation Information
Table 63. Sanofi Description and Business Overview
Table 64. Sanofi Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Sanofi Product
Table 66. Sanofi Recent Development
Table 67. HANSOH Corporation Information
Table 68. HANSOH Description and Business Overview
Table 69. HANSOH Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. HANSOH Product
Table 71. HANSOH Recent Development
Table 72. LUYE Corporation Information
Table 73. LUYE Description and Business Overview
Table 74. LUYE Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. LUYE Product
Table 76. LUYE Recent Development
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Novartis Product
Table 81. Novartis Recent Development
Table 82. GuiZhou YiBai Corporation Information
Table 83. GuiZhou YiBai Description and Business Overview
Table 84. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. GuiZhou YiBai Product
Table 86. GuiZhou YiBai Recent Development
Table 87. Lunan Corporation Information
Table 88. Lunan Description and Business Overview
Table 89. Lunan Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Lunan Product
Table 91. Lunan Recent Development
Table 92. Eli Lilly and Company Corporation Information
Table 93. Eli Lilly and Company Description and Business Overview
Table 94. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Eli Lilly and Company Product
Table 96. Eli Lilly and Company Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Oncology/Cancer Drugs Customers List
Table 100. Oncology/Cancer Drugs Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology/Cancer Drugs Product Picture
Figure 2. Global Oncology/Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Oncology/Cancer Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Oncology/Cancer Drugs Sales 2017-2028 (K MT)
Figure 5. United States Oncology/Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Oncology/Cancer Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Oncology/Cancer Drugs Sales 2017-2028 (K MT)
Figure 8. United States Oncology/Cancer Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Oncology/Cancer Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Oncology/Cancer Drugs Report Years Considered
Figure 11. Product Picture of Antimetabolite
Figure 12. Product Picture of Alkaloid drugs
Figure 13. Product Picture of Hormone
Figure 14. Product Picture of Targeted drug
Figure 15. Product Picture of Platinum-based drugs
Figure 16. Product Picture of Other
Figure 17. Global Oncology/Cancer Drugs Market Share by Type in 2022 & 2028
Figure 18. Global Oncology/Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Oncology/Cancer Drugs Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Oncology/Cancer Drugs Sales by Type (2017-2028) & (K MT)
Figure 21. Global Oncology/Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Oncology/Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 23. United States Oncology/Cancer Drugs Market Share by Type in 2022 & 2028
Figure 24. United States Oncology/Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Oncology/Cancer Drugs Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Oncology/Cancer Drugs Sales by Type (2017-2028) & (K MT)
Figure 27. United States Oncology/Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Oncology/Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 29. Product Picture of Blood Cancer
Figure 30. Product Picture of Breast Cancer
Figure 31. Product Picture of Gastrointestinal Cancer
Figure 32. Product Picture of Prostate Cancer
Figure 33. Product Picture of Respiratory/Lung Cancer
Figure 34. Product Picture of Other
Figure 35. Global Oncology/Cancer Drugs Market Share by Application in 2022 & 2028
Figure 36. Global Oncology/Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. Global Oncology/Cancer Drugs Sales Market Share in Value by Application (2017-2028)
Figure 38. Global Oncology/Cancer Drugs Sales by Application (2017-2028) & (K MT)
Figure 39. Global Oncology/Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 40. Global Oncology/Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 41. United States Oncology/Cancer Drugs Market Share by Application in 2022 & 2028
Figure 42. United States Oncology/Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 43. United States Oncology/Cancer Drugs Sales Market Share in Value by Application (2017-2028)
Figure 44. United States Oncology/Cancer Drugs Sales by Application (2017-2028) & (K MT)
Figure 45. United States Oncology/Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 46. United States Oncology/Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 47. North America Oncology/Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 48. North America Oncology/Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. U.S. Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Canada Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Europe Oncology/Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Europe Oncology/Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. Germany Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. France Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.K. Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Italy Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Russia Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Asia-Pacific Oncology/Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 59. Asia-Pacific Oncology/Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 60. China Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Japan Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. South Korea Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. India Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Australia Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Taiwan Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Indonesia Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Thailand Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Malaysia Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Philippines Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Latin America Oncology/Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 71. Latin America Oncology/Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Mexico Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Brazil Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Argentina Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Middle East & Africa Oncology/Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 76. Middle East & Africa Oncology/Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 77. Turkey Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Saudi Arabia Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. UAE Oncology/Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 80. Oncology/Cancer Drugs Value Chain
Figure 81. Oncology/Cancer Drugs Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs